Published in Clin Geriatr Med on November 01, 2009
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc (2010) 2.55
Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes Care (2014) 2.04
Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr Rev (2014) 1.71
Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol (2012) 1.49
Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol (2011) 1.42
Dimensions and correlates of quality of life according to frailty status: a cross-sectional study on community-dwelling older adults referred to an outpatient geriatric service in Italy. Health Qual Life Outcomes (2010) 1.29
Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care (2012) 1.22
BMI-mortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care (2012) 1.14
Overweight, mortality and survival. Obesity (Silver Spring) (2013) 1.13
Effect of age and dialysis vintage on obesity paradox in long-term hemodialysis patients. Am J Kidney Dis (2013) 1.00
Body mass index and mortality in elderly men and women: the Tromso and HUNT studies. J Epidemiol Community Health (2011) 0.99
'Obesity paradox' misunderstands the biology of optimal weight throughout the life cycle. Int J Obes (Lond) (2014) 0.99
Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health (2011) 0.98
Obesity and muscle strength as long-term determinants of all-cause mortality--a 33-year follow-up of the Mini-Finland Health Examination Survey. Int J Obes (Lond) (2013) 0.98
Socioeconomic inequalities in health after age 50: are health risk behaviors to blame? Soc Sci Med (2013) 0.96
Renal cell carcinoma survival and body mass index: a dose-response meta-analysis reveals another potential paradox within a paradox. Int J Obes (Lond) (2016) 0.94
Smaller cardiac cell size and reduced extra-cellular collagen might be beneficial for hearts of Ames dwarf mice. Int J Biol Sci (2010) 0.94
Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr (2013) 0.92
Comparing years of healthy life, measured in 16 ways, for normal weight and overweight older adults. J Obes (2012) 0.91
The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) (2013) 0.90
Weight status and sexual orientation: differences by age and within racial and ethnic subgroups. Am J Public Health (2013) 0.89
Obesity and mortality among older Thais: a four year follow up study. BMC Public Health (2010) 0.88
Effectiveness of weight loss interventions for obese older adults. Am J Health Promot (2013) 0.87
Overweight and class I obesity are associated with lower 10-year risk of mortality in Brazilian older adults: the Bambuí Cohort Study of Ageing. PLoS One (2012) 0.87
Associations between diabetes, leanness, and the risk of death in the Japanese general population: the Jichi Medical School Cohort Study. Diabetes Care (2012) 0.85
Polychlorinated biphenyls and links to cardiovascular disease. Environ Sci Pollut Res Int (2015) 0.85
Factors Associated with Functional Recovery among Older Intensive Care Unit Survivors. Am J Respir Crit Care Med (2016) 0.83
Prediction of remission after metabolic surgery using a novel scoring system in type 2 diabetes - a retrospective cohort study. J Diabetes Metab Disord (2014) 0.82
Body mass index and cognitive function: the potential for reverse causation. Int J Obes (Lond) (2015) 0.80
Prevalence and determinants of overweight and obesity in old age in Germany. BMC Geriatr (2015) 0.79
Association of body mass index with all-cause mortality in patients with diabetes: a systemic review and meta-analysis. Cardiovasc Diagn Ther (2016) 0.79
Trajectories of Body Mass Index and Their Associations With Mortality Among Older Japanese: Do They Differ From Those of Western Populations? Am J Epidemiol (2015) 0.79
Association Between Anthropometric Measures and Long-Term Survival in Frail Older Women: Observations from the Women's Health Initiative Study. J Am Geriatr Soc (2016) 0.79
Effect of weight loss on mortality in overweight and obese nursing home residents during a 5-year follow-up. Eur J Clin Nutr (2015) 0.78
Optimal Cutoff Points of Anthropometric Parameters to Identify High Coronary Heart Disease Risk in Korean Adults. J Korean Med Sci (2015) 0.78
Obesity, lifestyle risk-factors, and health service outcomes among healthy middle-aged adults in Canada. BMC Health Serv Res (2012) 0.78
Association between muscle mass and adipo-metabolic profile: a cross-sectional study in older subjects. Clin Interv Aging (2015) 0.77
Body mass index and stroke risk among patients with type 2 diabetes mellitus. Stroke (2014) 0.77
Obesity that makes kidney cancer more likely but helps fight it more strongly. J Natl Cancer Inst (2013) 0.76
Asthma in the elderly patient. Asthma Res Pract (2016) 0.76
The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults. Pharmacogenet Genomics (2015) 0.76
Physical Activity Modifies the Association between Dietary Protein and Lean Mass of Postmenopausal Women. J Acad Nutr Diet (2016) 0.75
Effect of proximal versus distal 50% enterectomy on nutritional parameters in rats preconditioned with a high-fat diet or regular chow. Sci Rep (2015) 0.75
A 3-year follow-up study of inpatients with lower limb ulcers: evidence of an obesity paradox? J Multidiscip Healthc (2012) 0.75
Being overweight in adults aged 70-75 is associated with a reduction in mortality risk compared with normal BMI. Evid Based Med (2010) 0.75
The effects of obesity on venous thromboembolism: A review. Open J Prev Med (2012) 0.75
Comparison of risks of cardiovascular events in the elderly using standard survival analysis and multiple-events and recurrent-events methods. BMC Med Res Methodol (2015) 0.75
Association between Adiposity and disability in the Lc65+ Cohort. J Nutr Health Aging (2017) 0.75
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Cachexia: a new definition. Clin Nutr (2008) 5.49
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med (2008) 4.98
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Epidemiology and risk profile of heart failure. Nat Rev Cardiol (2010) 4.88
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med (2010) 4.52
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA (2006) 4.30
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol (2005) 4.26
Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation (2008) 4.00
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 3.86
Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med (2010) 3.78
Obesity prevalence from a European perspective: a systematic review. BMC Public Health (2008) 3.67
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med (2013) 3.46
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation (2009) 3.43
Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med (2005) 3.38
Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol (2008) 3.35
State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail (2008) 3.35
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25
Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol (2012) 3.24
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol (2004) 3.08
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA (2012) 3.07
Use of aldosterone antagonists in heart failure. JAMA (2009) 3.00
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol (2002) 2.97
Activation of the peripheral endocannabinoid system in human obesity. Diabetes (2005) 2.90
Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J Am Coll Cardiol (2013) 2.89
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol (2006) 2.89
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J (2007) 2.80
High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail (2007) 2.75
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med (2013) 2.74
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis (2008) 2.74
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res (2004) 2.72
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol (2005) 2.71
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med (2012) 2.64
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail (2010) 2.64
Does AKI truly lead to CKD? J Am Soc Nephrol (2012) 2.61
Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol (2006) 2.59
Weight loss and the renin-angiotensin-aldosterone system. Hypertension (2005) 2.58
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol (2006) 2.57
Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation (2010) 2.53
An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol (2013) 2.47
Cardiac troponin and outcome in acute heart failure. N Engl J Med (2008) 2.41
A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg (2010) 2.41
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol (2008) 2.39
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation (2010) 2.32
Periadventitial fat releases a vascular relaxing factor. FASEB J (2002) 2.29
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int (2013) 2.23
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr (2008) 2.22
Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med (2013) 2.18
Sex differences in medical care and early death after acute myocardial infarction. Circulation (2008) 2.17
Retinol-binding protein 4 in human obesity. Diabetes (2006) 2.17
Need for increased awareness and evidence-based therapies for patients hospitalized for heart failure. JAMA (2013) 2.17
Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant (2006) 2.15
Four-variable risk model in men and women with heart failure. Circ Heart Fail (2013) 2.14
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol (2009) 2.14
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol (2005) 2.11
An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J (2006) 2.11
Visual assessment of brain magnetic resonance imaging detects injury to cognitive regulatory sites in patients with heart failure. J Card Fail (2013) 2.07
Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J (2008) 2.06
Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol (2007) 2.06
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol (2008) 2.05
Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol (2007) 2.05
Association between adiponectin and mediators of inflammation in obese women. Diabetes (2003) 2.05
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. Am Heart J (2012) 2.04
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation (2012) 2.03
Is an increased serum bicarbonate concentration during hemodialysis associated with an increased risk of death? Semin Dial (2014) 2.02
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J (2013) 1.99
Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail (2011) 1.99
The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int (2009) 1.98
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med (2007) 1.98
Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.95
Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis (2010) 1.95
An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension (2013) 1.95
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure. Circ Heart Fail (2009) 1.95
Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol (2007) 1.92
Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care? J Am Coll Cardiol (2011) 1.92
Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res (2004) 1.91
The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J Lipid Res (2009) 1.90
Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation (2003) 1.90
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol (2011) 1.90